Clinical trial

Lutetium-177-PSMA-617 in Low Volume Metastatic Prostate Cancer

NCT03828838

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-07-01

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2018-07-01Date precision: day

Registry last updated2019-11-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Neoplasmunresolved

Interventions

Lu-177 PSMA-617DRUG

Sponsors & collaborators

Radboud University Medical Centerlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03828838 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.